Hubei Goto BiopharmLtd Balance Sheet Health
Financial Health criteria checks 3/6
Hubei Goto BiopharmLtd has a total shareholder equity of CN¥1.0B and total debt of CN¥840.5M, which brings its debt-to-equity ratio to 81.8%. Its total assets and total liabilities are CN¥2.5B and CN¥1.5B respectively. Hubei Goto BiopharmLtd's EBIT is CN¥44.3M making its interest coverage ratio -267.7. It has cash and short-term investments of CN¥116.8M.
Key information
81.8%
Debt to equity ratio
CN¥840.51m
Debt
| Interest coverage ratio | -267.7x |
| Cash | CN¥116.79m |
| Equity | CN¥1.03b |
| Total liabilities | CN¥1.45b |
| Total assets | CN¥2.48b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300966's short term assets (CN¥772.7M) exceed its short term liabilities (CN¥712.1M).
Long Term Liabilities: 300966's short term assets (CN¥772.7M) exceed its long term liabilities (CN¥739.3M).
Debt to Equity History and Analysis
Debt Level: 300966's net debt to equity ratio (70.5%) is considered high.
Reducing Debt: 300966's debt to equity ratio has increased from 26.1% to 81.8% over the past 5 years.
Debt Coverage: 300966's debt is not well covered by operating cash flow (12.1%).
Interest Coverage: 300966 earns more interest than it pays, so coverage of interest payments is not a concern.